Trial Profile
Double-blind randomised controlled trial of pregabalin versus placebo in conjunction with palliative radiotherapy for malignant bone pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 07 Dec 2015 Results published in the Journal of Clinical Oncology
- 26 Jun 2012 United Kingdom Clinical Research Network reports accrual to date changed from 77% to 93%.
- 09 Jun 2012 Actual end date (30 Apr 2012) added as reported by European Clinical Trials Database record.